Total Share Holders Equity (after Deducting Minority Equity)
Profit (Loss) per Share
All figures are in (Actual) Saudi Arabia, Riyals
The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is
Net profit increases in general due to:1. Increase in sales in the following sectors:a. Specialty chemical sectorb. Power and steel sector2. Decrease in Selling and Distribution expenses in the following sectors:a. Pharmaceuticals sectorb. Power and steel sectorWhile noting that there is increase in other expenses and provision for impairment of financial assets expense.
The reason of the increase (decrease) in the net profit during the current quarter compared to the previous period of the current year is
Net profit increases in general due to:1. Decrease in Selling and Distribution expenses in Pharmaceuticals sector2. Decrease in provision for impairment for financial assets expense in the following sectors:a. Pharmaceuticals sectorb. Power and steel sector3. Decrease in Zakat and Income tax expenses in Pharmaceuticals sectorWhile noting that there is increase in other expenses.
Statement of the type of external auditor’s report
Reclassification of Comparison Items
No comparative figures for the previous period have been reclassified
1. Net Shareholders’ Equity at the end of the period was SR1,421,009,316 /- compared to SR1,223,695,759/- at the end of the similar period last year with an increase of 16%.
The Capital Market Authority and the Saudi Stock Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
The Board of Directors of Astra Industrial Group is pleased to invite the shareholders to participate and vote in the Ordinary General Assembly (First Meeting) which will be held on Sunday 11/04/2021 at 6:30PM via modern technology means using Tadawulaty System, in order to protect the shareholders health and prevent the spread of the Coronavirus (COVID-19), as per preventive and precautionary efforts and measures by the relevant health authorities and as an extension of the continuous efforts made by all government agencies in the Kingdom of Saudi Arabia to take the necessary preventive measures to prevent its spread.
Net profit increases in general due to: 1. Increase in sales and gross profit in the following sectors:
a. Pharmaceuticals b. Specialty chemicals
While noting that this increase was offset partially by impairment of financial assets.
2. Lower other expenses since in last year there was: Non-recurring negative impact as a result of the settlement of a subsidiary in Sudan in the pharmaceuticals sector the loan to its parent company in KSA realizing currency losses in the income statement which was partially offset by Non-recurring positive impact in the previous year in other income from fair values remeasurement of the company’s investment and loans to Tanmiya for steel company in accordance with IFRS
3. Decrease in financial charges in the following sectors:
a. Pharmaceuticals b. Specialty chemicals c. Power and Steel
4. Change in accounting for the losses in joint venture due to the consolidation of its financial statements
While noting that there was increase in Zakat expense